(Q33677537)

28 July 2017

1 reference

title

Citalopram in the treatment of depression and other potential uses in psychiatry (English)

1 reference

28 July 2017

0 references

Tan JY

1

1 reference

PubMed ID

10391413

28 July 2017

Levin GM

series ordinal

2

1 reference

PubMed ID

10391413

28 July 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

28 July 2017

1 reference

28 July 2017

19

1 reference

28 July 2017

675-689

1 reference

28 July 2017

6

1 reference

Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative

28 July 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Pharmacology of a new phthaline (Lu 10-171), with specific 5-HT uptake inhibiting properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Pharmacokinetic interaction study of citalopram and cimetidine in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Citalopram versus mianserin. A controlled, double-blind trial in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

The effect of age and concomitant treatment with other psychoactive drugs on serum concentrations of citalopram measured with a nonenantioselective method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Investigation of multiple dose citalopram on the pharmacokinetics and pharmacodynamics of racemic warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Antidepressant interactions with warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Fatal overdose with citalopram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Citalopram overdose--review of cases treated in Swedish hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

An open pilot study of citalopram for behavioral disturbances of dementia. Plasma levels and real-time observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Citalopram for post-stroke pathological crying

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Choosing an antidepressant: effectiveness based pharmacoeconomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

The kinetics of citalopram: single and multiple dose studies in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Kinetics of citalopram in man; plasma levels in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Kinetics of citalopram in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Tricyclic antidepressant plasma levels after augmentation with citalopram: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Lack of adverse interactions between concomitantly administered selegiline and citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

A comparison of the antidepressant action of citalopram and amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Citalopram-induced decreased libido

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Symptoms and signs of severe citalopram overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Long-term treatment of elderly individuals with emotional disturbances: an open study with citalopram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

The effect of citalopram in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

Child and adolescent obsessive-compulsive disorder treated with citalopram: findings from an open trial of 23 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.675.31538

10.1592/PHCO.19.9.675.31538

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10391413